The vagus nerve can control inflammatory response through a 'cholinergic anti-inflammatory pathway', which is mediated by the α7-nicotinic acetylcholine receptor (α7nAChR) on macrophages. However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain not well understood. In this study, we found that miR-124 is upregulated by cholinergic agonists in LPS-exposed cells and mice. Utilizing miR-124 mimic and siRNA knockdown, we demonstrated that miR-124 is a critical mediator for the cholinergic anti-inflammatory action. Furthermore, our data indicated that miR-124 modulates LPS-induced cytokine production by targeting signal transducer and activator of transcription 3 (STAT3) to decrease IL-6 production and TNF-α converting enzyme (TACE) to reduce TNF-α release. These results also indicate that miR-124 is a potential therapeutic target for the treatment of inflammatory diseases.
Introduction
During infections and injuries, the innate immune system is activated to release pro-inflammatory cytokines, such as IL-6 and TNF-α. They initiate the development of inflammatory responses that play an important role in controlling infection and promoting tissue repair [1] . However, the magnitude of the cytokine production and inflammation response is critical. An excessive response could be more harmful than the original insult, leading to the development of a variety of inflammatory and autoimmune diseases. Many studies have demonstrated that a number of humoral factors, such as glucocorticoids, act as potent modulators of the inflammatory response dur-ing various stress conditions [2, 3] . Recent investigations also indicated that the vagus nerve of the autonomic nerve system participates in the regulation of the inflammatory response [4, 5] . It has been shown that, when animals were challenged by infection or injury, the action potentials originating from the vagus nerve regulate T cells, which produce acetylcholine (ACh) that in turn acts on tissue macrophages and inhibits the production of pro-inflammatory cytokines [6, 7] . Interestingly, stimulation of the vagus nerve or nicotine, an agonist of the nicotinic ACh receptor, can attenuate the production of the pro-inflammatory cytokines and improve the survival of animals under various experimental conditions, including sepsis, haemorrhagic shock, and ischaemia-reperfusion injuries [4, [8] [9] [10] . Therefore, the cholinergic anti-inflammatory pathway is not only an important physiological mechanism, but also a promising target for therapeutic intervention.
The transmembrane receptors for ACh (AChR) are classified according to their relative sensitivities to nicotine and muscarine. While the muscarinic AChRs (mAChRs) are G-protein-coupled receptors, the nicotinic AChRs (nAChRs) are cation ion channels formed by Yang Sun et al. 1271 npg five subunits. A significant number of nAChR subunits have been identified, including ten α (α1-10), four β (β1-4), and one each of γ, δ and ε. The α7nAChR is one of the most abundant nAChRs in the brain and is also expressed in many non-neuronal cells, including epithelial, endothelial, immunological, and some cancer cells [11] . Intriguingly, α7nAChR is more permeable to Ca 2+ than other nAChRs and can utilize multiple amplification mechanisms to raise the intracellular calcium levels and activate multiple Ca 2+ -dependent kinases. One of the transcription factors activated is cAMP response element binding protein (CREB) [12, 13] . It has been shown that α7nAChR is essential for the cholinergic anti-inflammatory action, as stimulation of the vagus nerve could not inhibit TNF-α synthesis in α7nAChR-deficient mice [5, 14] . However, the intracellular mechanisms that link α7nAChR activation and pro-inflammatory cytokine production remain largely unclear. MicroRNAs (miRNAs) are non-coding transcripts of 18-25 nucleotides that are processed from large primary transcripts, which are commonly transcribed by RNA polymerase II [15, 16] . After initial processing by RNase Drosha in the nucleus, the pre-miRNA is transported to the cytoplasm where the miRNA hairpin is cleaved by endoribonuclease Dicer, forming a miRNA duplex. One of the RNA strands then binds to the RNAinducing silencing complex and guides the complex to the 3′-untranslated regions (UTRs) of target mRNAs, leading to their degradation or inhibition of their translation. It has been estimated that there are approximately 5 000-10 000 miRNAs in mammalian cells, which control the expression of more than 60% of the protein-coding genes. Increasing evidence indicates that most, if not all, physiological and pathological processes, including inflammatory responses, are modulated by miRNAs at multiple levels. Interestingly, miRNAs usually affect target gene expression in the range of 1.2-4.0 folds, suggesting that, rather than functioning as on-off switches for genes, they modulate and fine-tune the expression of target genes [17] . It is also worth noting that, although it is generally believed that the changes of miRNA expression are controlled at the level of transcription, proteins that are involved in generating miRNA from its precursor can also exert their influences [18] . We found that miR-124 is highly induced by α7nAChR activation. miR-124 mediates the cholinergic anti-inflammatory action by inhibiting LPS-induced production of pro-inflammatory cytokines, and a miR-124 agomir could effectively protect mice from septic shock. Additionally, both α7nAChR agonist and miR-124 mimic inhibit LPS-induced IL-6 mRNA production, but not that of TNF-α. This is consistent with a previous report that ACh decreased IL-1-in-duced IL-6 production in fibroblast-like synoviocytes by reducing the IL-6 mRNA level [19] . Our further analysis indicated that miR-124 targets STAT3, which is required for LPS-induced IL-6 transcription, as well as TACE, which is required for the maturation of TNF-α protein.
These results reveal novel mechanisms of the cholinergic anti-inflammatory action and provide valuable targets and strategies for therapeutic intervention of inflammatory diseases.
Results

TNF-α and IL-6 expression are inhibited by α7nAChR activation at post-transcriptional and transcriptional level, respectively
To understand the mechanism responsible for the cholinergic anti-inflammatory action, we examined the effect of nicotine, an α7nAChR agonist, on cytokine production in LPS-treated macrophage cell line RAW264.7. Among the pro-inflammatory cytokines, IL-1β was undetectable in the supernatant and IL-10 level was not affected by nicotine as previously reported [4] . Interestingly, although nicotine decreased TNF-α and IL-6 production in a dose-dependent manner, it only reduced the mRNA level of IL-6 ( Figure 1A and 1B). Similar results were also obtained using primary peritoneal macrophages from mice ( Figure 1C and 1D). These findings prompted us to ask whether miRNAs, which could affect both the stability and translation of mRNA, are involved in the cholinergic anti-inflammatory action. When Dicer, the key enzyme in miRNA maturation, was knocked down, the inhibitory effects of nicotine on pro-inflammatory cytokine production were significantly attenuated. The inhibition ratio of nicotine on LPS-induced IL-6 production was reduced from 77.3% to 26.1%. The inhibition of nicotine on TNF-α production was reduced modestly by knockdown of Dicer (85% to 76%) ( Figure 1E ).
miR-124 is induced by α7nAChR activation
A number of miRNAs have been found to regulate inflammation and immunity. miR-155 and miR-125b are involved in the regulation of TNF-α production; miR-146a/b was proposed to control Toll-like receptor (TLR) signaling; miR-181a modulates the production of CD4 and CD8 double-positive T cells; miR-124 was found to inhibit the activation of microglial cells; and miR-223 negatively regulates the proliferation and differentiation of neutrophils [20] [21] [22] [23] . To identify the potential miRNAs involved in the cholinergic anti-inflammatory action, expression of these miRNAs was examined by quantitative PCR. Interestingly, while the levels of miR-125b, miR-125b-1, miR-146a, miR-146b, miR-155, miR-181a, miR-181c and miR-223 were not affected by nicotine treatment, miR-124 increased by nearly 4-fold in the presence of nicotine (Figure 2A ). This effect was also observed in mice peritoneal macrophages ( Figure 2B ). As shown in Figure 2C , expression of miR-124 increased 3 h after exposure to LPS and nicotine, and reached the highest level at 9 h post-treatment. Meanwhile, the inhibition of IL-6 and TNF-α secretions also became significant 9 h after nicotine treatment, suggesting that miR-124 could mediate the cholinergic anti-inflammatory action.
Both genetic and pharmacological approaches were utilized to determine whether miR-124 upregulation is npg dependent on α7nAChR activation. Nicotine failed to suppress the production of LPS-induced pro-inflammatory cytokines in peritoneal macrophages from α7nAChRdeficient mice as reported (Supplementary information, Figure S1A ). Neither could it upregulate the level of miR-124 in these cells ( Figure 2D ). Similarly, MLA, a selective α7nAChR antagonist, abolished the upregulation of miR-124 expression by nicotine ( Figure 2E and Supplementary information, Figure S1B ) in RAW264.7 cells. Furthermore, the α7nAChR-selective agonist PNU inhibited IL-6 production in RAW264.7 cells in a dosedependent manner (Supplementary information, Figure  S1C ), and it increased miR-124 expression more effectively (by nearly 8-fold) than nicotine (by approximately 4-fold) when 5 µM drug was used ( Figure 2F ). These results indicate that upregulation of miR-124 by nicotine requires α7nAChR.
miR-124 mediates the differential effects of α7nAChR activation on the expression of TNF-α and IL-6 in macrophages
To directly assess the effect of miR-124 on the production of pro-inflammatory cytokines, a miR-124 mimic was transfected into RAW264. Figure S2A ) resulted in a significant reduction in LPS-induced IL-6 and TNF-α production, but had no effect on IL-10 production (data not shown). Interestingly, the miR-124 mimic decreased the level of IL-6 mRNA in a dose-dependent manner, but not that of TNF-α ( Figure 3B ), suggesting that it does not directly block signaling through TLR4. To further evaluate the role of miR-124 in the anti-inflammatory action of nicotine, LPS-induced miR-124 was knocked down in the RAW264.7 cells. As shown in Figure 3C , miR-124 knockdown (Supplementary information, Figure S2B ) significantly attenuated the inhibitory effect of nicotine on LPS-induced IL-6 and TNF-α production. Furthermore, miR-124 knockdown abolished the inhibitory effect of nicotine on the level of IL-6 mRNA, but had no influence on the level of TNF-α mRNA ( Figure 3D ). These data demonstrate that miR-124 is required and sufficient for the cholinergic anti-inflammatory action under these experimental conditions.
miR-124 is essential for the anti-inflammatory effect of the cholinergic pathway in LPS-induced septic mice
The critical role of miR-124 in cultured cells led us to speculate whether it is involved in the anti-inflammatory action of nicotine in vivo. Among the tissues and organs examined in normal mice, brain and colon express relatively high levels of miR-124 ( Figure 4A ). After injection of LPS, expression of miR-124 was significantly increased in the spleen, brain and colon (by 10-, 3-and 2-fold, respectively; Figure 4A ). In the presence of nicotine (2 mg/kg body weight), which effectively decreased LPS-induced serum IL-6 and TNF-α levels (Supplementary information, Figure S3A ), the miR-124 level was further increased by 2-fold in the spleen and brain ( Figure 4A ). The administration of the α7nAChRselective agonist PNU inhibited pro-inflammatory cytokine production (Supplementary information, Figure  S3B ) and increased the level of miR-124 in the spleen by 6.1-fold ( Figure 4B ). Interestingly, the serum miR-124 level was also elevated by LPS injection and was further increased with the addition of nicotine (data not shown). These data indicate that the spleen is one of the major miR-124-producing peripheral organs in response to LPS and nicotine, which is consistent with the finding that the spleen is the main target of the cholinergic antiinflammatory pathway [24, 25] .
To determine whether miR-124 plays an essential role in the cholinergic anti-inflammatory action, BALB/ c mice were injected intravenously with the miR-124 mimic agomir (Supplementary information, Figure S3C ). As shown in Figure 4C and 4D, agomir significantly in-creased the survival rate and decreased serum IL-6 and TNF-α levels of mice that were given a lethal dose of LPS. Under our experimental conditions, administration of 2 mg/kg nicotine also significantly increased the survival rate of LPS-injected mice (Supplementary information, Figure S3D ). However, when these mice were given the antisence miR-124 vivo-morpholino through the tail vein to decrease miR-124 (Supplementary information, Figure  S3E) , the protective effect of nicotine on survival rate and production of serum IL-6 and TNF-α was significantly attenuated ( Figure 4E and 4F) . These data indicate that miR-124 plays an important role in the anti-shock effect of the cholinergic anti-inflammatory action.
miR-124 targets STAT3 to attenuate LPS-induced IL-6 production
Using TargetScan (http://www.targetscan.org) to search for targets of miR-124, we found that the 3′-UTR of mouse STAT3 mRNA contains two putative miR-124 target sites (Supplementary information, Figure S4A ). To determine whether the stability of STAT3 mRNA is potentially regulated by miR-124, we constructed a reporter plasmid by inserting the cDNA corresponding to the 3′-UTR of mouse STAT3 mRNA into the 3′-region of the firefly luciferase gene. Similar plasmids containing the 3′-UTRs of IL-6 and TNF-α mRNAs were also constructed, although both of them were not predicted to be the targets of miR-124. In cells transfected with the reporter plasmid containing 3′-UTR of STAT3 mRNA, the miR-124 mimic significantly decreased luciferase activity, whereas it did not significantly alter luciferase activity in cells transfected with reporter constructs that contain the 3′-UTR of IL-6 or TNF-α ( Figure 5A ). The effects of miR-124 on STAT3 were then examined in RAW264.7 cells. As shown in Figure 5B , the level of STAT3 decreased by approximately 50% when the cells were treated with the miR-124 mimic for 36 h. Intriguingly, the level of STAT3 increased modestly when the cells were exposed to the miR-124 inhibitor ( Figure 5B ), suggesting that miR-124 is a modulator of STAT3 in the absence of inflammatory stimuli. Furthermore, akin to nicotine treatment, which reduced LPS-induced STAT3 phosphorylation (Tyr705) in both RAW264.7 cells and peritoneal macrophages (Supplementary information, Figure S4B ), transfection of the miR-124 mimic also resulted in a significant decrease in the LPS-induced STAT3 tyrosine phosphorylation ( Figure 5C ). As both miR-124 mimic and inhibitor did not change the mRNA level of STAT3 in macrophages (Supplementary information, Figure S4C ), these data indicate that miR-124 likely targets STAT3 through translational inhibition.
To assess whether STAT3 is required for LPS-induced cytokine production, specific siRNA was used to knock down STAT3 in RAW264.7 cells (Supplementary information, Figure S4D ). As shown in Figure 5D , STAT3 siRNA significantly reduced LPS-induced IL-6 produc-tion at both mRNA and protein levels. However, STAT3 knockdown did not affect LPS-induced TNF-α protein and mRNA production. In these STAT3-knockdown cells, the miR-124 mimic did not further reduce the level of LPS-induced IL-6 production, although it still decreased TNF-α production ( Figure 5E ). Furthermore, LPS induced the production of IL-6, but not that of TNF-α in mouse embryo fibroblasts (MEFs). As shown in Figure 5F , LPS could not induce IL-6 and its mRNA in MEFs from STAT3-deficient mice (Supplementary information, Figure S4E ). These results demonstrate that STAT3 is critical for IL-6 production in response to LPS and that miR-124 can target STAT3 to inhibit IL-6 production at the transcriptional level.
miR-124 targets TACE to modulate mature TNF-α production
As miR-124 reduced LPS-induced TNF-α production without decreasing the level and stability of its mRNA (Supplementary information, Figure S5A ), the translation of TNF-α mRNA or post-translational processing might be its target. It has been shown that TNF-α is synthesized as a membrane-anchored precursor (pro-TNF-α) and released from cells by the action of proteases, including TACE, which is regarded as the most important TNF sheddase [26] . Mice lacking tissue inhibitor of matrix metalloproteinases 3 (TIMP3), the endogenous inhibitor of TACE, have an exacerbated response to LPS [27] , whereas TACE inactivation in mice offers strong protection from septic shock by preventing a TNF-α increase in serum [28] . Therefore, we examined whether nicotine affects the processing of pro-TNF-α. As shown in Figure  6A , nicotine treatment significantly increased pro-TNF-α and decreased mature TNF-α production in LPS-treated macrophages. Furthermore, transfection of the miR-124 mimic also led to the accumulation of pro-TNF-α and a decrease of mature TNF-α in LPS-stimulated RAW264.7 cells, indicating that miR-124 might mediate the cholinergic inhibiting action on TNF-α production by preventing the maturation of TNF-α.
Interestingly, it was indicated by TargetScan that the 3′-UTR of TACE contains two putative miR-124 target sites (Supplementary information, Figure S5B ). The wild-type and mutant 3′-UTR luciferase reporter constructs of TACE were made. As shown in Figure 6B , the miR-124 mimic significantly decreased while the inhibitor significantly increased luciferase activity in HEK293 cells (which have nearly 45 times higher level of miR-124 than that in RAW264.7 macrophages, data not shown) transfected with the wild-type TACE 3′-UTR reporter. However, these effects were abolished when cells were transfected with mutant TACE 3′- Figure S5C ). As shown in Figure 6D , transfection of a suboptimal amount of miR-124 mimic decreased LPSinduced TNF-α production by ~25%, which was not further decreased by knockdown of TACE. As miR-124 did not change the level of TACE mRNA (Supplementary information, Figure S5D ), these results suggest that miR-124 inhibits the translation of TACE mRNA to modulate TNF-α production.
Discussion
Despite tremendous progress in numerous aspects of the medical sciences, sepsis remains one of the leading causes of death in the clinic. Many studies have demonstrated that dysregulated production of pro-inflammatory cytokines plays a critical role in triggering sepsis-induced circulation shock and multiple organ failure, which are largely responsible for the mortality [29] . Biologics that neutralize pro-inflammatory cytokines (i.e., anti-TNF antibodies, recombinant soluble IL-1 and TNF-receptors) have been successfully used in the treatment of certain inflammatory diseases, including rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, and psoriasis [30] [31] [32] . However, dozens of clinical trials attempting to address sepsis-associated inflammation and organ dysfunction achieved only limited, if any, success in improv-npg ing the outcomes of severe sepsis [29] . There are at least two potential explanations for these failures: (1) multiple cytokines are involved in severe sepsis; (2) each cytokine may exert both protective and damaging effects during sepsis. Therefore, it has been proposed that the most important issue now is to understand the anti-inflammatory response of the host [33] . A series of elegant studies by Tracey and colleagues identified the cholinergic antiinflammatory pathway [34] . Three treatment options, i.e., electrical stimulation of the vagus nerve, pharmacological agonists of α7nAChR, and modulation of neuron function, have been found effective in various disease models, including sepsis, arthritis, and ischemia-reperfusion injuries [34] . However, vagus nerve stimulation in humans is an invasive procedure and is not feasible under many circumstances. Although nicotine has been used with some success in the treatment of ulcerative colitis, which featured high STAT3 phosphorylation [35] , it is not specific for α7nAChR. The high dose needed to generate anti-septic effects is associated with severe side effects and toxicity. Therefore, exploring the mechanisms of signal transduction through α7nAChR may provide more specific and effective targets for therapeutic interventions that modulate inflammatory responses.
Since the initial discovery of their regulatory roles in the development of the nematode, miRNAs have emerged as key modulators in many biological processes, including the inflammatory response. Interestingly, it has been shown that TLR/NF-κB activation is capable of inducing multiple miRNAs, including miR-146a and miR-155 [21, 22] . While miR-155 targets negative regulators such as SHIP and SOCS1 and enhances inflammatory responses, miR-146a downregulates TRAF6 and IRAK1, which participate in TLR4-mediated signal transduction, and reduces pro-inflammatory cytokine production, demonstrating that multiple miRNAs can modulate one signal pathway and a single miRNA can affect multiple molecules in the same pathway. We have found in this study that the cholinergic signal-induced miR-124 can target two different proteins that are not directly related to TLR4 signaling, but indirectly affect the outcomes of LPS stimulation, revealing an additional layer of complexity of miRNA actions. It is worth noting that miR-124 can also regulate the expression of IκBζ [36] , which has been found to be indispensible for the transactivation of a subset of NF-κB target genes, including IL-6 and IL-12p40, but not TNF and NO in macrophages [37] . Whether the inhibition of IκBζ by miR-124 occurs in LPS-stimulated macrophages and whether this inhibition plays a role in the cholinergic anti-inflammatory action remain to be further investigated. As previously reported and shown in Figure 4 , miR-124 is highly expressed in the central nervous system and microglia, which function as macrophages in the CNS. It has been shown recently that miR-124 can target transcription factor C/EBP-α and promote microglia quiescence [20] , suggesting that C/EBP-α might also be involved in the cholinergic antiinflammatory action.
The intracellular mechanisms of the cholinergic antiinflammatory action have been investigated in a number of different systems. In HBE16 airway epithelial cells, it was shown that nicotine reduces TNF-α expression at the transcriptional level by blocking NF-κB activation [38] . In RAW267.4 cells, it was found that nicotine inhibits LPS-induced NO synthesis by suppressing p42/44 MAPK and S6K1-mediated STAT3 phosphorylation at serine 727 [39] . The cholinergic agonist nicotine and GTS-21 also suppress IL-6-mediated endothelial cell activation, presumably by decreasing the phosphorylation of JAK2 and STAT3 [40] . Intriguingly, it was reported that engagement of α7nAChR is able to activate STAT3, which is responsible for the inhibition of LPSinduced production of pro-inflammatory cytokines [41] . However, subsequent studies participated by the same group and our results have shown that LPS-induced STAT3 phosphorylation is inhibited by α7nAChR activation ( Figure 5 ) [42] . There are contradictory reports regarding whether STAT3 and its phosphorylation can directly regulate TNF-α production in macrophages following LPS stimulation, which is at least partially due to the production of multiple cytokines that might crosstalk [42] [43] [44] [45] [46] . The ability of miR-124, which is induced modestly by LPS alone (Figure 2C ), to target STAT3 and TACE and affect TNF-α secretion suggests that it could connect different pathways. In contrast, it has been demonstrated that IL-6 activates STAT3 to regulate the expression of target genes, and activation of STAT3 upregulates IL-6 in a number of cancer cells [47] , forming a positive feedback loop. The significance of this loop is illustrated by the finding that STAT3-deficient MEFs produced little IL-6 after LPS treatment ( Figure  5 ). Downregulation of STAT3 by miR-124 appears to restrict the positive feedback, leading to a reduction in IL-6 production ( Figure 7) . Consistent with our results, it has been shown very recently that miR-124 can target STAT3 and regulate the differentiation of bone marrowderived mesenchymal cells [48] . Additionally, a study in hepatocytes indicated that miR-124 also targets IL-6 receptor [49] , suggesting that regulating the expression of the IL-6 receptor may also restrict the positive feedback loop. It would be interesting to further examine whether the lack of the receptor will affect LPS-induced IL-6 production and whether miR-124 can target the receptor in macrophages. 
Materials and Methods
Reagents LPS, nicotine, methyllycaconitine (MLA) and PNU282987 (PNU) were purchased from Sigma (St Louis, MO, USA). Antibodies specific to STAT3 and phospho-STAT3 (Tyr705) were from Cell Signaling (Danvers, MA, USA). Anti-Dicer antibody was from IMGENEX (San Diego, CA, USA). Anti-GAPDH antibody was from Protein Tech (Chicago, IL, USA). Anti-TACE antibody was from AbCam (Cambridge, UK). The miR-124 mimic and miR-124 inhibitor (mmu-miR-124 mature sequence: 5′-UAA GGC ACG CGG UGA AUG CC-3′) for in vitro studies were from Dharmacon (Lafayette, CO, USA). For in vivo studies, the miR-124 agomir (modified miR-124 mimic) and the negative control were from RiboBio (Guangzhou, China), and the antisense miR-124 vivo-morpholino (5′-GGC ATT CAC CGC GTG CCT TAA TTG T-3′) and the control vivo-morpholino (5′-GGC AAT GAC CCC GTC CCT TAA TTC T-3′) were from GeneTools (Philomath, OR, USA).
Cell culture and transfection
Mouse macrophage cell line RAW264.7 and human HEK293 cell line were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured as described [50] . These cells were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Enriched thioglycollate broth (Sigma)-elicited mouse peritoneal macrophages from wild-type C57BL/6 and α7nAChR-deficient mice were prepared and cultured as previously described [51] . STAT3-deficient MEFs were obtained from Dr Luis G Rodriguez (SAIC, MD, USA). Wild-type MEFs were prepared from E13.5 mouse embryos according to standard procedures. MEFs were cultured in DMEM supplemented with 10% FBS, 100 units/ml of penicillin and 100 µg/ml of streptomycin in a humidified incubator with 5% CO 2 .
Animals
BALB/c and C57BL/6 mice (18-22 g) were purchased from Sino-British SIPPR/BK Laboratory Animals (Shanghai, China). The α7nAChR-deficient mice (B6.129S7-Chrna7tm1Bay, Stock Number: 00323) were obtained from Jackson Laboratory (Bar Harbor, MA, USA). Mice were 5-6 weeks of age at the start of the experiments. All animals were maintained in animal rooms at 22 °C on a 12-h light/dark cycle with free access to water and a standard rodent diet. All animal experiments were undertaken in accordance with the National Institute of Health's "Guide for the Care and Use of Laboratory Animals", with the approval of the Scientific Investigation Board of Second Military Medical University.
RNA interference
The Dicer-specific siRNAs were 5′-GCC GAU CUC UAA UUA CGU ATT-3′ (sense) and 5′-UAC GUA AUU AGA GAU CGG CGC-3′ (antisense). The STAT3-specific siRNAs were 5′-GGG UGA AAU UGA CCA GCA ATT-3′ (sense) and 5′-UUG Figure 7 miR-124 mediates the cholinergic anti-inflammatory action through targeting STAT3 and TACE. Nicotine upregulates miR-124 expression through activating α7nAChR in LPS-stimulated macrophages. STAT3 is critical for IL-6 production in response to LPS. Its activation leads to increased transcription and production of IL-6, which in turn induces STAT3 phosphorylation via IL-6 receptor and further increases IL-6 transcription, forming a positive feedback loop. miR-124 targets STAT3, and decreases STAT3 and its phosphorylation, resulting in the reduction of IL-6 at the transcription level. In addition, miR-124 targets TACE to modulate TNF-α maturation.
